indazoles has been researched along with staurosporine in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 8 (88.89) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Almeida, S; Gil, J; Oliveira, CR; Rego, AC | 1 |
| Levis, M; Murphy, KM; Pratz, KW; Rajkhowa, T; Sato, T; Stine, A | 1 |
| Borgne-Sanchez, A; Brenner, C; Buron, N; Chen, ZX; Gallerne, C; Jacotot, E; Le Bras, M; Lemaire, C; Lemoine, A; Martel, C; Mayola, E; Pervaiz, S; Sharaf el dein, O; Touat, Z | 1 |
| Kiyoi, H | 1 |
| Burnett, A; Galkin, S; Knapper, S; Levis, M; Sato, T; Small, D; Smith, BD; White, P; Yang, X | 1 |
| Akita, K; Fujii, I; Gouda, M; Ishihama, Y; Kirii, Y; Kitagawa, D; Narumi, Y; Sugiyama, N; Yokota, K | 1 |
| Ender, M; Galli, P; Madon, J; Riewald, M; Schuepbach, RA | 1 |
| Alcántara-Hernández, R; García-Sáinz, JA; Hernández-Méndez, A | 1 |
| Chen, B; Zhou, F | 1 |
2 review(s) available for indazoles and staurosporine
| Article | Year |
|---|---|
[FLT3 kinase inhibitors for the treatment of acute leukemia].
Topics: Acute Disease; Clinical Trials as Topic; Drug Design; Enzyme Inhibitors; fms-Like Tyrosine Kinase 3; Humans; Indazoles; Leukemia; Mutation; Piperazines; Quinazolines; Signal Transduction; Staurosporine | 2010 |
Acute myeloid leukemia carrying ETV6 mutations: biologic and clinical features.
Topics: Benzamides; ETS Translocation Variant 6 Protein; Gene Rearrangement; Humans; Indazoles; Leukemia, Myeloid, Acute; Mutation; Oncogene Proteins, Fusion; Proto-Oncogene Proteins c-ets; Repressor Proteins; Staurosporine; Tumor Microenvironment | 2018 |
7 other study(ies) available for indazoles and staurosporine
| Article | Year |
|---|---|
Cytosolic and mitochondrial ROS in staurosporine-induced retinal cell apoptosis.
Topics: Adenine; Allopurinol; Animals; Antioxidants; Apoptosis; Arachidonic Acids; Benzoquinones; Blotting, Western; Calcium; Carbon; Caspase 3; Caspases; Cell Death; Cell Survival; Chick Embryo; Chromans; Coloring Agents; Cytosol; DNA Fragmentation; Enzyme Inhibitors; Glutathione; In Situ Nick-End Labeling; Indazoles; Metalloporphyrins; Mitochondria; Neurons; Nitric Oxide Synthase; Oligomycins; Protein Isoforms; Reactive Oxygen Species; Retina; Rotenone; Staurosporine; Tetrazolium Salts; Thiazoles; Time Factors; Ubiquinone; Uncoupling Agents; Xanthine Oxidase | 2003 |
FLT3-mutant allelic burden and clinical status are predictive of response to FLT3 inhibitors in AML.
Topics: Alleles; Antineoplastic Agents; Benzenesulfonates; Benzothiazoles; Carbazoles; Cell Death; Cell Line, Tumor; Drug Resistance, Neoplasm; fms-Like Tyrosine Kinase 3; Furans; Humans; Indazoles; Indoles; Leukemia, Myeloid, Acute; Mutation; Niacinamide; Phenylurea Compounds; Phosphorylation; Piperazines; Pyridines; Pyrroles; Sorafenib; Staurosporine; Sunitinib | 2010 |
The fourth isoform of the adenine nucleotide translocator inhibits mitochondrial apoptosis in cancer cells.
Topics: Adenine Nucleotide Translocator 3; Antineoplastic Agents; Apoptosis; Caspase 9; Cell Proliferation; Cell Shape; Cytoprotection; HeLa Cells; Humans; Hydrogen Peroxide; Indazoles; Isoenzymes; Mitochondria; Mitochondrial ADP, ATP Translocases; Oxidative Phosphorylation; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-bcl-2; Staurosporine; Superoxides | 2010 |
FLT3 ligand impedes the efficacy of FLT3 inhibitors in vitro and in vivo.
Topics: Antineoplastic Agents; Benzenesulfonates; Carbazoles; Cells, Cultured; Drug Antagonism; fms-Like Tyrosine Kinase 3; Furans; Humans; Indazoles; Inhibitory Concentration 50; Leukemia, Myeloid, Acute; Membrane Proteins; Multicenter Studies as Topic; Niacinamide; Phenylurea Compounds; Piperazines; Protein Kinase Inhibitors; Pyridines; Randomized Controlled Trials as Topic; Sorafenib; Staurosporine; Treatment Outcome | 2011 |
Characterization of kinase inhibitors using different phosphorylation states of colony stimulating factor-1 receptor tyrosine kinase.
Topics: Animals; Benzamides; Benzenesulfonates; Binding, Competitive; Cell Line; Dasatinib; Dose-Response Relationship, Drug; Humans; Imatinib Mesylate; Indazoles; Indoles; Kinetics; Niacinamide; Phenylurea Compounds; Phosphorylation; Piperazines; Protein Kinase Inhibitors; Pyridines; Pyrimidines; Pyrroles; Receptor, Macrophage Colony-Stimulating Factor; Sorafenib; Spodoptera; Staurosporine; Sulfonamides; Sunitinib; Surface Plasmon Resonance; Thiazoles; Transfection | 2012 |
Protease-activated receptor-1 cleaved at R46 mediates cytoprotective effects.
Topics: Amino Acid Sequence; Antibodies; Arginine; Binding Sites, Antibody; Cytoprotection; Endothelial Cells; HEK293 Cells; Humans; Indazoles; Molecular Sequence Data; Peptide Fragments; Protein C; Protein Conformation; Receptor, PAR-1; Receptors, Thrombin; RNA Interference; Signal Transduction; Staurosporine; Structure-Activity Relationship; Thrombin; Transfection; Urea | 2012 |
The phosphoinositide-dependent protein kinase 1 inhibitor, UCN-01, induces fragmentation: possible role of metalloproteinases.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cricetinae; Indazoles; Metalloproteases; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Pyrazoles; Pyrimidines; Pyruvate Dehydrogenase Acetyl-Transferring Kinase; Staurosporine; Sulfonamides | 2014 |